Enlivex Ltd. (Nasdaq: ENLV) ("Enlivex" or the "Company"), a quality longevity company powered by a prediction markets treasury, today announced a 1-for-16 reverse split (the “Reverse Split”) of its ...
In a release issued under the same headline earlier today, please note that in the third paragraph of the release, the "Reverse Stock Split date" should be "October 26, 2026," not "October 19, 2026," ...
Enlivex (ENLV) will implement a 1-for-16 reverse stock split effective October 27, 2026, with shares trading on a split-adjusted basis on Nasdaq. The company’s issued and outstanding shares will ...
Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health and neuroprosthetics company pioneering fully implanted hearing solutions, today announced that it will ...
Split-adjusted trading began Oct. 20, 2026, under the temporary symbol NGTFDLOS ANGELES, Oct. 20, 2026 (GLOBE NEWSWIRE) -- via IBN -- , Inc. (OTC Pink: NGTFD) (“Nightfood” or the “Company”), doing ...
Propanc Biopharma ( PPCB) announced that its Board of Directors has approved a 1-for-10 reverse stock split of the company's issued and outstanding common shares, aimed at restoring compliance with ...
The reverse stock split is intended to increase the market price per share of the Company’s common stock to regain compliance with the minimum bid continued listing requirement of The Nasdaq Capital ...
Odyssey Marine Exploration (ISIN US6761182012) announced a 1-for-25 reverse stock split on October 16, 2026, with adjusted ...
The Company expects that the reverse stock split will increase the price per share of the Company's common stock, and is part of the Company's strategy to regain compliance with the $1.00 minimum bid ...
Class A shares will trade on a split-adjusted basis on Nasdaq beginning October 26 under the existing symbol "HKPD." The new CUSIP number will be G6365B112. Fractional shares will be rounded up to the ...
Fintel on MSN
Enlivex Therapeutics Ltd. announces 1-for-16 reverse share split effective October 27, 2026
Enlivex Therapeutics Ltd. announced that its Board of Directors has determined to effect a reverse share split of its ordinary shares at a ratio of 1-for-16. The ordinary shares will begin trading on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results